Microvast (MVST) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
10 Nov, 2026Executive summary
Q3 revenue fell 62.8% YoY to $45.805M as sales volume dropped 62.2% to 189.6 MWh; gross margin was 5.2% and net loss was $76.800M.
Substantial doubt about the ability to continue as a going concern remains; projected cash may not cover obligations over the next 12 months without financing, debt relief or further cost reductions.
Financial highlights
Q3 revenue was $45.805M versus $123.287M; gross profit was $2.367M versus $46.412M YoY.
Q3 operating loss was $66.667M versus operating income of $14.9M; net loss was $76.800M versus $1.5M.
9M revenue was $193.679M versus $331.117M; operating loss was $76.3M versus operating income of $39.2M, and net loss was $40.6M versus $45.8M.
9M net results included a $58.0M fair-value gain on the convertible loan, partly offset by a $15.4M foreign-exchange loss.
Operating cash use was $65.4M in 9M 2026 versus $59.5M generated in 9M 2025; investing used $5.6M and financing generated $23.3M.
Outlook and guidance
Priorities include cost control, targeted workforce actions, aligning production and spending with confirmed demand, preserving liquidity, and refinancing, extending or restructuring near-term debt; potential asset sales are also under consideration.
Cost reductions and discretionary capex deferrals are underway, but implementation costs have strained and may continue to strain near-term liquidity.
Huzhou Phase 3.2 equipment installation and commissioning are complete; ramp depends on demand, yields, qualification, efficiency and working capital, and the line may operate below capacity.
Clarksville pack assembly is substantially complete; full-scale construction depends on additional financing or strategic partnerships.
$41.7M of bonds plus accrued interest is due by Jan. 31, 2027; $84.0M of short-term bank loans mature over the next 12 months.
Latest events from Microvast
- Director election and advisory votes headline the 2026 meeting; the Board favors annual say-on-pay.MVST
Proxy filing - Proxy card sets four voting matters, with the Board favoring annual say-on-pay votes.MVST
Proxy filing - Board recommends annual say-on-pay votes and approval of the director, auditor, and compensation proposals.MVST
Proxy filing - Revenue fell 4.5% and gross margin dropped to 29.5% as capacity expansions progressed.MVST
Q2 2026 - Revenue dropped 48% year-over-year, but margin resilience and fair value gains supported results.MVST
Q1 2026 - Record revenue and positive adjusted EBITDA, despite margin hit from inventory impairment.MVST
Q4 2025 - Q3 profit and 27% revenue growth driven by EMEA, but liquidity and expansion risks persist.MVST
Q3 2024 - Q2 revenue up 12% to $83.7M, EMEA surged, but net loss widened on impairment and liquidity risks.MVST
Q2 2024 - Record revenue, margin gains, and $401M backlog support strong 2025 growth outlook.MVST
Q4 2024